Merck antibody reduces risk of Clostridium difficile recurrence: study
An experimental antibody developed by Merck & Co Inc was shown in pivotal studies to reduce by about 10 percentage points the risk that infection with Clostridium difficile bacterium, which can cause a deadly diarrhea, will recur. In the United States, C. diff... More »
